Chennai Meenakshi Multispeciality Hospital Limited has announced that its Board of Directors will convene on February 11, 2026, to review and approve the company's third quarter financial results for FY26. The meeting represents a key milestone in the hospital's quarterly reporting cycle as it prepares to disclose its financial performance for the period ended December 31, 2025.

Board Meeting Details

The board meeting has been scheduled with specific parameters to ensure compliance with regulatory requirements and proper governance protocols.

Regulatory Compliance and Trading Window Closure

The company has implemented strict measures to comply with SEBI regulations regarding insider trading. As part of these compliance requirements, a comprehensive trading window closure has been put in effect to prevent any potential misuse of unpublished price-sensitive information.

The trading window restrictions apply to multiple stakeholder categories and remain in effect for an extended period to ensure complete regulatory adherence.

Corporate Communication and Documentation

The formal notice was communicated to BSE Limited under reference number CMMH/BSE/2025-26/71, demonstrating the company's commitment to transparent and timely disclosure. The communication was signed by R. Gomathi, Chairman and Managing Director, and follows the company's previous correspondence regarding trading window closure dated December 31, 2025.

The announcement adheres to Regulation 29(1)(a) and Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, ensuring all stakeholders receive adequate notice of the upcoming financial results disclosure. This systematic approach to corporate governance reflects the hospital's dedication to maintaining high standards of regulatory compliance and shareholder communication.

Chennai meenakshi multispeciality Hospital Limited has appointed Ms. M.S. Anantha Lakshmi as its new Company Secretary and Compliance Officer, effective January 9, 2026. The appointment was formally communicated to BSE Limited on January 10, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Appointment Details

The company's board meeting held on January 9, 2026, approved the appointment of Ms. Anantha Lakshmi to the key compliance role. The appointment follows the resignation of the previous Company Secretary and Compliance Officer, whose resignation details were submitted to the exchange in July 2025.

Professional Qualifications

Ms. Anantha Lakshmi brings extensive professional credentials to her new role. She is an Associate Member of the Institute of Company Secretaries of India (ICSI) with membership number A46694. Her educational qualifications include:

• Bachelor of Commerce (B.Com.)
• Cost and Management Accountant (C.M.A.)
• Master of Business Administration (M.B.A.)
• Associate Company Secretary (ACS)
• CA Intermediate qualification

Additionally, she holds membership with the Institute of Cost and Works Accountants of India, demonstrating her comprehensive understanding of financial and compliance matters.

Regulatory Compliance

The appointment notification was made in accordance with multiple regulatory requirements, including Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also complied with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Company Background

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, operates as an ISO 9001:2008 and ISO 14001:2004 certified hospital. The company is headquartered at Luz Church Road, Mylapore, Chennai, and trades on BSE with scrip code 523489. The appointment strengthens the company's compliance framework as it continues its healthcare operations in Chennai.